Breaking News Instant updates and real-time market news.

ITW

Illinois Tool Works

$177.98 /

+2.17 (+1.23%)

08:09
01/31/20
01/31
08:09
01/31/20
08:09

Illinois Tool Works sees FY20 EPS $7.65-$8.05, consensus $7.98

The company initiated full-year EPS guidance in a range of $7.65 to $8.05 per share. At current levels of demand, organic growth is forecast to be in the range of zero to two percent. Foreign currency translation and divestitures are projected to reduce revenues by one percentage point each. PLS impact is forecast to moderate to approximately 50 basis points. Operating margin is expected to improve and be in a range of 24.5 to 25 percent, with enterprise initiatives contributing approximately 100 basis points. Free cash flow is expected to be greater than 100 percent of net income. The Company expects an effective tax rate in the range of 23.5 to 24.5 percent and plans to repurchase approximately $2 billion of its shares in 2020.

  • 31

    Jan

ITW Illinois Tool Works
$177.98 /

+2.17 (+1.23%)

01/14/20 Wells Fargo
Illinois Tool Works price target raised to $200 from $190 at Wells Fargo
09/23/19 Goldman Sachs
Illinois Tool Works downgraded to Sell from Neutral at Goldman Sachs
07/29/19 Credit Suisse
Illinois Tool Works price target raised to $152 from $124 at Credit Suisse
07/10/19 Deutsche Bank
Deutsche says buy Stanley, sell Illinois Tool Works and Parker-Hannifin into Q2

TODAY'S FREE FLY STORIES

Conference/Events
American Society for Radiation Oncology to hold virtual annual meeting » 08:40
10/26/20
10/26
08:40
10/26/20
08:40
VRAY

ViewRay

$3.06 /

-0.06 (-1.92%)

, ARAY

Accuray

$3.11 /

-0.015 (-0.48%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BDX

Becton Dickinson

$240.30 /

-0.88 (-0.36%)

, BSX

Boston Scientific

$37.16 /

+0.29 (+0.79%)

, DNA

Bought by RHHBY

$0.00 /

+ (+0.00%)

, HTHIY

Hitachi

$0.00 /

+ (+0.00%)

, HOLX

Hologic

$67.89 /

-0.11 (-0.16%)

, MDT

Medtronic

$111.42 /

-0.47 (-0.42%)

, MYGN

Myriad Genetics

$14.63 /

-0.04 (-0.27%)

, NVCR

Novocure

$123.72 /

-1.23 (-0.98%)

, SNY

Sanofi

$49.33 /

+0.39 (+0.80%)

, SMMNY

Siemens Healthineers

$0.00 /

+ (+0.00%)

, SYK

Stryker

$221.95 /

-2.645 (-1.18%)

, TDY

Teledyne

$340.93 /

+4.36 (+1.30%)

, WTKWY

Wolters Kluwer

$0.00 /

+ (+0.00%)

, VAR

Varian

$172.51 /

+0.79 (+0.46%)

ASTRO Virtual Annual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRAY ViewRay
$3.06 /

-0.06 (-1.92%)

ARAY Accuray
$3.11 /

-0.015 (-0.48%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BDX Becton Dickinson
$240.30 /

-0.88 (-0.36%)

BSX Boston Scientific
$37.16 /

+0.29 (+0.79%)

HTHIY Hitachi
$0.00 /

+ (+0.00%)

HOLX Hologic
$67.89 /

-0.11 (-0.16%)

MDT Medtronic
$111.42 /

-0.47 (-0.42%)

MYGN Myriad Genetics
$14.63 /

-0.04 (-0.27%)

NVCR Novocure
$123.72 /

-1.23 (-0.98%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

SYK Stryker
$221.95 /

-2.645 (-1.18%)

TDY Teledyne
$340.93 /

+4.36 (+1.30%)

WTKWY Wolters Kluwer
$0.00 /

+ (+0.00%)

VAR Varian
$172.51 /

+0.79 (+0.46%)

VRAY ViewRay
$3.06 /

-0.06 (-1.92%)

10/07/20 Piper Sandler
ViewRay amended agreement with Siemens favorable, says Piper Sandler
06/23/20 Piper Sandler
Piper Sandler bullish on ViewRay as 1-year prostate data adds to data compendium
06/16/20 Cantor Fitzgerald
ViewRay assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
ViewRay assumed with an Overweight at Cantor Fitzgerald
ARAY Accuray
$3.11 /

-0.015 (-0.48%)

09/28/20 Lake Street
CMS 'pouring fuel on the fire' for Accuray with APM rule, says Lake Street
09/18/20 Cowen
New CMS model should provide tailwind for Accuray, says Cowen
04/17/20 JPMorgan
Varian Medical price target lowered to $90 from $100 at JPMorgan
01/21/20 BTIG
Accuray upgraded to Buy from Neutral at BTIG
BAYRY Bayer
$0.00 /

+ (+0.00%)

10/21/20 Morgan Stanley
Bayer price target lowered to EUR 68 from EUR 82 at Morgan Stanley
10/13/20 Barclays
Bayer downgraded to Equal Weight from Overweight at Barclays
10/08/20 Kepler Cheuvreux
Bayer upgraded to Buy from Hold at Kepler Cheuvreux
10/05/20 UBS
Bayer price target lowered to EUR 85 from EUR 110 at UBS
BDX Becton Dickinson
$240.30 /

-0.88 (-0.36%)

10/08/20 Goldman Sachs
Baxter pump delays speak more to FDA protocols than actual product, says Goldman
10/08/20 KeyBanc
Investors will view Baxter pump news 'somewhat negatively,' says KeyBanc
10/02/20
Fly Intel: Top five analyst upgrades
10/02/20 Goldman Sachs
Becton Dickinson upgraded to Conviction Buy from Buy at Goldman Sachs
BSX Boston Scientific
$37.16 /

+0.29 (+0.79%)

10/16/20 Stifel
Boston Scientific dip seems like opportunity to add to positions, says Stifel
10/16/20 Piper Sandler
Boston Scientific TAVR delay to pressure shares, says Piper Sandler
09/16/20 Truist
Boston Scientific initiated with a Buy at Truist
09/11/20 Wolfe Research
Boston Scientific initiated with a Peer Perform at Wolfe Research
DNA Bought by RHHBY
$0.00 /

+ (+0.00%)

HTHIY Hitachi
$0.00 /

+ (+0.00%)

10/15/20 Jefferies
Hitachi initiated with a Buy at Jefferies
07/20/20 SMBC Nikko
Hitachi downgraded to Neutral from Outperform at SMBC Nikko
04/22/20 UBS
Hitachi downgraded to Neutral from Buy at UBS
HOLX Hologic
$67.89 /

-0.11 (-0.16%)

10/07/20 Jefferies
FDA expansion of APTIMA's EUA a 'clear endorsement' for Hologic, says Jefferies
08/27/20 Morgan Stanley
Abbott 'may change the game' in COVID testing with BinaxNOW, says Morgan Stanley
07/30/20 Needham
Hologic price target raised to $78 from $64 at Needham
07/30/20 Wells Fargo
Hologic price target raised to $80 from $63 at Wells Fargo
MDT Medtronic
$111.42 /

-0.47 (-0.42%)

10/16/20 Morgan Stanley
Morgan Stanley positively biased on Medtronic, but awaits execution
10/16/20 Citi
Citi opens 'positive catalyst watch' on DexCom
10/15/20 Cowen
Medtronic moving closer to med-tech growth leaders, says Cowen
10/14/20 Piper Sandler
Medtronic raises revenue growth outlook to 5% from 4%, says Piper Sandler
MYGN Myriad Genetics
$14.63 /

-0.04 (-0.27%)

08/17/20 Piper Sandler
ACOG recommendation 'extremely' positive for Natera and Progenity, says Piper
06/11/20 Piper Sandler
Palmetto coverage language unclear about Myriad's GeneSight, says Piper Sandler
05/06/20 JPMorgan
Myriad Genetics price target lowered to $12 from $14 at JPMorgan
05/06/20 Piper Sandler
Myriad Genetics price target lowered to $14 from $20 at Piper Sandler
NVCR Novocure
$123.72 /

-1.23 (-0.98%)

10/05/20 Piper Sandler
Bristol-Myers approval removes some Novocure revenue upside, says Piper Sandler
09/23/20
Fly Intel: Top five analyst initiations
09/23/20 Northland
Novocure initiated with an Outperform at Northland
09/18/20
Fly Intel: Top five analyst downgrades
SNY Sanofi
$49.33 /

+0.39 (+0.80%)

10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
09/29/20 Berenberg
Sanofi initiated with a Hold at Berenberg
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

10/06/20 Deutsche Bank
Siemens Healthineers price target lowered to EUR 39 at Deutsche Bank
10/02/20 Citi
Citi opens '30-day negative catalyst watch' on Siemens Healthineers
09/04/20 DZ Bank
Siemens Healthineers upgraded to Buy from Hold at DZ Bank
08/18/20 UBS
Siemens Healthineers price target raised to EUR 40 from EUR 39 at UBS
SYK Stryker
$221.95 /

-2.645 (-1.18%)

10/12/20 Cleveland Research
Stryker estimates raised at Cleveland Research
10/12/20 BTIG
BTIG raises price targets on Zimmer Biomet, Stryker, iRhythm Technologies
10/06/20
Fly Intel: Top five analyst initiations
10/06/20 Northland
Stryker initiated with a Market Perform at Northland
TDY Teledyne
$340.93 /

+4.36 (+1.30%)

10/07/20
Fly Intel: Top five analyst initiations
10/07/20 Goldman Sachs
Teledyne initiated with a Neutral at Goldman Sachs
08/25/20 Wolfe Research
Teledyne initiated with an Outperform at Wolfe Research
07/15/20 Jefferies
Jefferies upgrades Teledyne to Buy, sees Q2 as likely trough
WTKWY Wolters Kluwer
$0.00 /

+ (+0.00%)

08/24/20 Berenberg
Wolters Kluwer downgraded to Hold at Berenberg with growth seen as set to slow
08/24/20 Berenberg
Wolters Kluwer downgraded to Hold from Buy at Berenberg
08/06/20 JPMorgan
Wolters Kluwer price target raised to EUR 65 from EUR 62 at JPMorgan
08/06/20 Morgan Stanley
Wolters Kluwer price target raised to EUR 77 from EUR 71 at Morgan Stanley
VAR Varian
$172.51 /

+0.79 (+0.46%)

10/07/20 Piper Sandler
ViewRay amended agreement with Siemens favorable, says Piper Sandler
08/11/20
Fly Intel: Top five analyst downgrades
08/10/20 BTIG
Varian downgraded to Neutral from Buy at BTIG
08/06/20 UBS
Varian downgraded to Neutral from Buy at UBS
VRAY ViewRay
$3.06 /

-0.06 (-1.92%)

ARAY Accuray
$3.11 /

-0.015 (-0.48%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BDX Becton Dickinson
$240.30 /

-0.88 (-0.36%)

BSX Boston Scientific
$37.16 /

+0.29 (+0.79%)

HOLX Hologic
$67.89 /

-0.11 (-0.16%)

MDT Medtronic
$111.42 /

-0.47 (-0.42%)

MYGN Myriad Genetics
$14.63 /

-0.04 (-0.27%)

NVCR Novocure
$123.72 /

-1.23 (-0.98%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

SYK Stryker
$221.95 /

-2.645 (-1.18%)

TDY Teledyne
$340.93 /

+4.36 (+1.30%)

VAR Varian
$172.51 /

+0.79 (+0.46%)

  • 22
    May
  • 21
    May
  • 04
    Dec
BAYRY Bayer
$0.00 /

+ (+0.00%)

BDX Becton Dickinson
$240.30 /

-0.88 (-0.36%)

BSX Boston Scientific
$37.16 /

+0.29 (+0.79%)

MDT Medtronic
$111.42 /

-0.47 (-0.42%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

ARAY Accuray
$3.11 /

-0.015 (-0.48%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BDX Becton Dickinson
$240.30 /

-0.88 (-0.36%)

BSX Boston Scientific
$37.16 /

+0.29 (+0.79%)

HOLX Hologic
$67.89 /

-0.11 (-0.16%)

MDT Medtronic
$111.42 /

-0.47 (-0.42%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

SYK Stryker
$221.95 /

-2.645 (-1.18%)

VAR Varian
$172.51 /

+0.79 (+0.46%)

BSX Boston Scientific
$37.16 /

+0.29 (+0.79%)

HOLX Hologic
$67.89 /

-0.11 (-0.16%)

MDT Medtronic
$111.42 /

-0.47 (-0.42%)

VAR Varian
$172.51 /

+0.79 (+0.46%)

Hot Stocks
Global Partners boosts quarterly dividend to 50c per share » 08:39
10/26/20
10/26
08:39
10/26/20
08:39
GLP

Global Partners

$14.31 /

+0.18 (+1.27%)

Global Partners announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GLP Global Partners
$14.31 /

+0.18 (+1.27%)

GLP Global Partners
$14.31 /

+0.18 (+1.27%)

03/24/20 Barclays
Global Partners upgraded to Equal Weight from Underweight at Barclays
01/29/20 JPMorgan
JPMorgan downgrades four MLPs to Underweight from Neutral
01/29/20 JPMorgan
Global Partners downgraded to Underweight from Neutral at JPMorgan
01/07/20 Wells Fargo
Global Partners downgraded to Underweight at Wells Fargo
GLP Global Partners
$14.31 /

+0.18 (+1.27%)

Recommendations
Ameris Bancorp price target raised to $33 from $27 at Raymond James » 08:39
10/26/20
10/26
08:39
10/26/20
08:39
ABCB

Ameris Bancorp

$29.12 /

-0.02 (-0.07%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABCB Ameris Bancorp
$29.12 /

-0.02 (-0.07%)

ABCB Ameris Bancorp
$29.12 /

-0.02 (-0.07%)

10/19/20 Stephens
Ameris Bancorp resumed with an Overweight at Stephens
09/23/20 Raymond James
Ameris Bancorp upgraded at Raymond James, YTD underperformance unjustified
09/23/20 Raymond James
Ameris Bancorp upgraded to Strong Buy from Outperform at Raymond James
07/29/20 Piper Sandler
Ameris Bancorp resumed with an Overweight at Piper Sandler
ABCB Ameris Bancorp
$29.12 /

-0.02 (-0.07%)

Hot Stocks
Nurix appoints Robert Tjian as chairman of Scientific Advisory Board » 08:39
10/26/20
10/26
08:39
10/26/20
08:39
NRIX

Nurix Therapeutics

$28.21 /

+0.76 (+2.77%)

Nurix Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NRIX Nurix Therapeutics
$28.21 /

+0.76 (+2.77%)

08/18/20
Fly Intel: Top five analyst initiations
08/18/20 JPMorgan
Nurix Therapeutics initiated with an Overweight at JPMorgan
08/18/20 Needham
Nurix Therapeutics initiated with a Buy at Needham
08/18/20 Stifel
Nurix Therapeutics initiated with a Buy at Stifel
NRIX Nurix Therapeutics
$28.21 /

+0.76 (+2.77%)

  • 24
    Jul
NRIX Nurix Therapeutics
$28.21 /

+0.76 (+2.77%)

Recommendations
Pinterest price target raised to $57 from $37 at JPMorgan » 08:38
10/26/20
10/26
08:38
10/26/20
08:38
PINS

Pinterest

$52.99 /

+2.19 (+4.31%)

JPMorgan analyst Doug…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PINS Pinterest
$52.99 /

+2.19 (+4.31%)

PINS Pinterest
$52.99 /

+2.19 (+4.31%)

07:17 Today KeyBanc
Pinterest price target raised to $60 from $44 at KeyBanc
10/22/20 OTR Global
Pinterest upgraded to Positive from Mixed at OTR Global
10/21/20
Fly Intel: Top five analyst upgrades
10/21/20 Goldman Sachs
Pinterest upgraded to Buy from Neutral at Goldman Sachs
PINS Pinterest
$52.99 /

+2.19 (+4.31%)

PINS Pinterest
$52.99 /

+2.19 (+4.31%)

PINS Pinterest
$52.99 /

+2.19 (+4.31%)

PINS Pinterest
$52.99 /

+2.19 (+4.31%)

Hot Stocks
Resverlogix announces publication on apabetalone in Medicine in Drug Discovery » 08:38
10/26/20
10/26
08:38
10/26/20
08:38

Resverlogix announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Huntington Bancshares upgraded to Outperform at Wedbush » 08:38
10/26/20
10/26
08:38
10/26/20
08:38
HBAN

Huntington Bancshares

$10.47 /

+0.1 (+0.96%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HBAN Huntington Bancshares
$10.47 /

+0.1 (+0.96%)

HBAN Huntington Bancshares
$10.47 /

+0.1 (+0.96%)

07:10 Today Wedbush
Huntington Bancshares upgraded to Outperform from Neutral at Wedbush
07/31/20 Wolfe Research
Huntington Bancshares initiated with an Outperform at Wolfe Research
06/03/20 Stephens
Stephens upgrades Huntington Bancshares to Overweight on trends in key markets
06/03/20 Stephens
Huntington Bancshares upgraded to Overweight from Equal Weight at Stephens
HBAN Huntington Bancshares
$10.47 /

+0.1 (+0.96%)

HBAN Huntington Bancshares
$10.47 /

+0.1 (+0.96%)

HBAN Huntington Bancshares
$10.47 /

+0.1 (+0.96%)

HBAN Huntington Bancshares
$10.47 /

+0.1 (+0.96%)

Recommendations
Proofpoint price target lowered to $124 from $155 at DA Davidson » 08:37
10/26/20
10/26
08:37
10/26/20
08:37
PFPT

Proofpoint

$107.47 /

-0.96 (-0.89%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFPT Proofpoint
$107.47 /

-0.96 (-0.89%)

PFPT Proofpoint
$107.47 /

-0.96 (-0.89%)

08/26/20 Wedbush
Proofpoint assumed with an Outperform at Wedbush
08/19/20
Fly Intel: Top five analyst upgrades
08/19/20 Morgan Stanley
Proofpoint upgraded to Overweight from Equal Weight at Morgan Stanley
07/31/20 Northland
Proofpoint price target raised to $153 from $145 at Northland
PFPT Proofpoint
$107.47 /

-0.96 (-0.89%)

Recommendations
JPMorgan continues to like top pick Amazon into Q3 results » 08:37
10/26/20
10/26
08:37
10/26/20
08:37
AMZN

Amazon.com

$3,203.69 /

+28.72 (+0.90%)

JPMorgan analyst Doug…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

08:14 Today Bernstein
Bernstein looking at Q3 as an investment period for Amazon
10/20/20 Citi
Citi likes Amazon head of Q3 results despite Prime Day language
10/19/20 Piper Sandler
Amazon Prime Day sales up 49% year-over-year, says Piper Sandler
10/16/20 Citi
Citi questions if Amazon's Prime Day may disappoint compared to last year
AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

Earnings
TriCo Bancshares reports Q3 EPS 59c, consensus 59c » 08:36
10/26/20
10/26
08:36
10/26/20
08:36
TCBK

TriCo Bancshares

$30.42 /

+0.01 (+0.03%)

Reports Q3 book value per…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCBK TriCo Bancshares
$30.42 /

+0.01 (+0.03%)

Upgrade
Live Oak Bancshares upgraded to Strong Buy from Outperform at Raymond James » 08:36
10/26/20
10/26
08:36
10/26/20
08:36
LOB

Live Oak Bancshares

$33.68 /

+0.69 (+2.09%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LOB Live Oak Bancshares
$33.68 /

+0.69 (+2.09%)

LOB Live Oak Bancshares
$33.68 /

+0.69 (+2.09%)

08:23 Today Truist
Live Oak Bancshares price target raised to $43 from $28 at Truist
06:29 Today Raymond James
Live Oak Bancshares upgraded to Strong Buy from Outperform at Raymond James
09/29/20
Fly Intel: Top five analyst initiations
09/29/20 Raymond James
Live Oak Bancshares initiated with an Outperform at Raymond James
LOB Live Oak Bancshares
$33.68 /

+0.69 (+2.09%)

LOB Live Oak Bancshares
$33.68 /

+0.69 (+2.09%)

Hot Stocks
Hudbay Minerals provides update on inspection of 777 mine » 08:36
10/26/20
10/26
08:36
10/26/20
08:36
HBM

Hudbay Minerals

$5.11 /

+0.035 (+0.69%)

Hudbay Minerals provides…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HBM Hudbay Minerals
$5.11 /

+0.035 (+0.69%)

HBM Hudbay Minerals
$5.11 /

+0.035 (+0.69%)

10/22/20 National Bank
Hudbay Minerals price target raised to C$7 from C$6.75 at National Bank
10/13/20 Scotiabank
Hudbay Minerals price target raised to C$7.25 from C$5 at Scotiabank
10/13/20 Scotiabank
Hudbay upgraded to Outperform on copper leverage at Scotiabank
10/13/20 Scotiabank
Hudbay Minerals upgraded to Outperform from Sector Perform at Scotiabank
HBM Hudbay Minerals
$5.11 /

+0.035 (+0.69%)

Conference/Events
The SEC to hold a virtual roundtable discussion » 08:36
10/26/20
10/26
08:36
10/26/20
08:36

The SEC staff and the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Granite Construction announces two airport projects totaling $15M » 08:35
10/26/20
10/26
08:35
10/26/20
08:35
GVA

Granite Construction

$20.30 /

+0.2 (+1.00%)

Granite announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GVA Granite Construction
$20.30 /

+0.2 (+1.00%)

GVA Granite Construction
$20.30 /

+0.2 (+1.00%)

06/25/20 DA Davidson
Granite Construction price target lowered to $17 from $30 at DA Davidson
01/13/20 Goldman Sachs
Granite Construction downgraded to Sell from Neutral at Goldman Sachs
10/28/19
Granite Construction downgraded to Neutral from Buy at DA Davidson
10/28/19 DA Davidson
Granite Construction downgraded to Neutral from Buy at DA Davidson
GVA Granite Construction
$20.30 /

+0.2 (+1.00%)

GVA Granite Construction
$20.30 /

+0.2 (+1.00%)

GVA Granite Construction
$20.30 /

+0.2 (+1.00%)

Hot Stocks
Collegium announces publication of postmarketing analysis of Xtampza ER » 08:35
10/26/20
10/26
08:35
10/26/20
08:35
COLL

Collegium Pharmaceutical

$19.37 /

+0.26 (+1.36%)

Collegium Pharmaceutical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COLL Collegium Pharmaceutical
$19.37 /

+0.26 (+1.36%)

COLL Collegium Pharmaceutical
$19.37 /

+0.26 (+1.36%)

07/14/20 BWS Financial
Collegium Pharmaceutical initiated with a Sell at BWS Financial
05/27/20 Guggenheim
Guggenheim starts coverage of four pain treatment makers with two Buys
05/26/20 Guggenheim
Collegium Pharmaceutical initiated with a Neutral at Guggenheim
03/23/20 SunTrust
SunTrust lowers price targets among Pharmaceuticals due to COVID-19
COLL Collegium Pharmaceutical
$19.37 /

+0.26 (+1.36%)

Initiation
Chindata initiated with an Overweight at Morgan Stanley » 08:35
10/26/20
10/26
08:35
10/26/20
08:35
CD

Chindata

$13.58 /

+0.03 (+0.22%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 30
    Sep
CD Chindata
$13.58 /

+0.03 (+0.22%)

Upgrade
First Midwest upgraded to Outperform from Market Perform at Raymond James » 08:34
10/26/20
10/26
08:34
10/26/20
08:34
FMBI

First Midwest

$12.59 /

+ (+0.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FMBI First Midwest
$12.59 /

+ (+0.00%)

FMBI First Midwest
$12.59 /

+ (+0.00%)

04:56 Today Raymond James
First Midwest upgraded to Outperform from Market Perform at Raymond James
03/06/20 SunTrust
First Midwest downgraded to Hold from Buy at SunTrust
FMBI First Midwest
$12.59 /

+ (+0.00%)

Recommendations
Netflix narrative to focus less on subs, more on profitability, says Wells Fargo » 08:34
10/26/20
10/26
08:34
10/26/20
08:34
NFLX

Netflix

$488.28 /

+3.01 (+0.62%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$488.28 /

+3.01 (+0.62%)

NFLX Netflix
$488.28 /

+3.01 (+0.62%)

10/21/20 JPMorgan
Netflix weakness on earnings a buying opportunity, says JPMorgan
10/21/20 KeyBanc
KeyBanc sees Netflix stock weakness as 'an overreaction'
10/21/20 Wells Fargo
Netflix price target raised to $510 from $470 at Wells Fargo
10/21/20 Canaccord
Netflix profits outperformed while subscriber growth slowed, says Canaccord
NFLX Netflix
$488.28 /

+3.01 (+0.62%)

NFLX Netflix
$488.28 /

+3.01 (+0.62%)

NFLX Netflix
$488.28 /

+3.01 (+0.62%)

NFLX Netflix
$488.28 /

+3.01 (+0.62%)

Hot Stocks
Liquid Media commercializes retro games, enters deal with Throwback » 08:34
10/26/20
10/26
08:34
10/26/20
08:34
YVR

Liquid Media

$1.65 /

-0.04 (-2.37%)

Liquid Media Group has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YVR Liquid Media
$1.65 /

-0.04 (-2.37%)

Initiation
Mission Produce initiated with an Overweight at JPMorgan » 08:34
10/26/20
10/26
08:34
10/26/20
08:34
AVO

Mission Produce

$13.24 /

-0.18 (-1.34%)

JPMorgan analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVO Mission Produce
$13.24 /

-0.18 (-1.34%)

06:25 Today Citi
Mission Produce initiated with a Buy at Citi
06:23 Today Stephens
Mission Produce initiated with an Overweight at Stephens
  • 01
    Oct
AVO Mission Produce
$13.24 /

-0.18 (-1.34%)

Hot Stocks
Spectrum Brands acquires pet treat and toy company, Armitage Pet Care » 08:34
10/26/20
10/26
08:34
10/26/20
08:34
SPB

Spectrum Brands

$60.54 /

-0.8 (-1.30%)

Spectrum Brands Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPB Spectrum Brands
$60.54 /

-0.8 (-1.30%)

10/05/20 Oppenheimer
Spectrum Brands price target raised to $68 from $58 at Oppenheimer
09/08/20 RBC Capital
Spectrum Brands price target raised to $80 from $62 at RBC Capital
07/16/20 Deutsche Bank
Spectrum Brands price target raised to $53 from $47 at Deutsche Bank
03/30/20 Oppenheimer
Spectrum Brands price target lowered to $50 from $80 at Oppenheimer
SPB Spectrum Brands
$60.54 /

-0.8 (-1.30%)

Hot Stocks
Keurig Dr Pepper: Snapple, CORE transition to 100% recycled plastic bottles » 08:33
10/26/20
10/26
08:33
10/26/20
08:33
KDP

Keurig Dr Pepper

$29.18 /

-0.37 (-1.25%)

Keurig Dr Pepper…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KDP Keurig Dr Pepper
$29.18 /

-0.37 (-1.25%)

KDP Keurig Dr Pepper
$29.18 /

-0.37 (-1.25%)

10/20/20 Jefferies
National Beverage upgraded to Hold on better La Croix market share at Jefferies
08/27/20 Jefferies
Keurig Dr Pepper has long runway for pod category growth, says Jefferies
08/26/20
Fly Intel: Top five analyst upgrades
08/26/20 Morgan Stanley
Keurig Dr Pepper upgraded to Overweight on coffee 'boost' at Morgan Stanley
KDP Keurig Dr Pepper
$29.18 /

-0.37 (-1.25%)

  • 18
    Aug
  • 03
    Aug
  • 21
    May
  • 05
    Mar
KDP Keurig Dr Pepper
$29.18 /

-0.37 (-1.25%)

General news
Chicago Fed National Activity Index data reported » 08:33
10/26/20
10/26
08:33
10/26/20
08:33

September Chicago Fed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Forte Biosciences receives fast track designation for FB-401 from FDA » 08:33
10/26/20
10/26
08:33
10/26/20
08:33
FBRX

Forte Biosciences

$35.37 /

+1.92 (+5.74%)

Forte Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FBRX Forte Biosciences
$35.37 /

+1.92 (+5.74%)

FBRX Forte Biosciences
$35.37 /

+1.92 (+5.74%)

09/24/20 Chardan
Forte Biosciences price target raised to $110 from $60 at Chardan
09/18/20 Chardan
Seres Therapeutics downgraded to Neutral from Buy at Chardan
09/10/20 Chardan
Forte Biosciences price target raised to $60 from $45 at Chardan
08/28/20 Chardan
Forte Biosciences upgraded to Buy from Neutral at Chardan
FBRX Forte Biosciences
$35.37 /

+1.92 (+5.74%)

FBRX Forte Biosciences
$35.37 /

+1.92 (+5.74%)

Upgrade
Crown Castle upgraded to Outperform from Market Perform at Raymond James » 08:33
10/26/20
10/26
08:33
10/26/20
08:33
CCI

Crown Castle

$158.54 /

+2.285 (+1.46%)

Raymond James analyst Ric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CCI Crown Castle
$158.54 /

+2.285 (+1.46%)

CCI Crown Castle
$158.54 /

+2.285 (+1.46%)

04:55 Today Raymond James
Crown Castle upgraded to Outperform from Market Perform at Raymond James
08/20/20
Fly Intel: Top five analyst downgrades
08/20/20 Wells Fargo
Wells Fargo downgrades Crown Castle on fiber, 2020 guidance risk
08/20/20 Wells Fargo
Crown Castle downgraded to Equal Weight from Overweight at Wells Fargo
CCI Crown Castle
$158.54 /

+2.285 (+1.46%)

CCI Crown Castle
$158.54 /

+2.285 (+1.46%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.